Yu-Waye Chu

FATE

Yu-Waye Chu serves as officer: Chief Medical Officer at Fate Therapeutics, Inc. (FATE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

8 trades

$1.19M

Net Position

Net Seller

$1.19M

Companies Traded

CTMX, FATE

Active Period

Apr 2021 – Mar 2026

8 total trades

Most Recent

Sell CTMX

Mar 19, 2026 · $136.7K

Yu-Waye Chu's Insider Trading at Fate Therapeutics, Inc. (FATE)

Buys

0 · $0.00

Sells

6 · $1.05M

Total Shares Bought

Total Shares Sold

29,159

FATE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 19, 2023	Sell	2,532	$6.57	$16.6K	142,993
Jan 11, 2023	Sell	7,825	$5.24	$41.0K	143,208
Apr 21, 2022	Sell	4,062	$35.37	$143.7K	151,033
Jan 13, 2022	Sell	3,965	$48.51	$192.3K	122,211
Dec 13, 2021	Sell	7,500	$51.46	$385.9K	131,161
Apr 20, 2021	Sell	3,275	$83.30	$272.8K	67,200

Yu-Waye Chu's Insider Trading at CytomX Therapeutics, Inc. (CTMX)

Buys

0 · $0.00

Sells

2 · $139.1K

Total Shares Bought

Total Shares Sold

25,304

CTMX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 19, 2026	Sell	21,279	$6.42	$136.7K	189,446
Mar 18, 2025	Sell	4,025	$0.60	$2.4K	0

Related Insiders

Christopher Ogden

officer: Chief Financial Officer

CTMXSell · Jun 17, 2026

TAHL CINDY

See Remarks

FATESell · May 21, 2026

Bahram Valamehr

President and CEO

FATESell · May 21, 2026

BELVIN MARCIA

officer: SVP, Chief Scientific Officer

CTMXSell · Mar 19, 2026

Sean A. McCarthy

director, officer: CEO

CTMXSell · Mar 19, 2026

Explore More Insider Trading Data

FATE Insider Trading Activity

View all insider trades at Fate Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity